Ginny Mason
Ginny Mason/LinkedIn

Ginny Mason: Why Clinical Trial Access Needs to Change for Inflammatory Breast Cancer Patients

Ginny Mason, Executive Director of the Inflammatory Breast Cancer Research Foundation, shared a post on LinkedIn:

“Clinical trials can be a great option for treatment but it can be tough to find one that includes IBC patients. Not everyone can travel a distance to find a trial, insurance may not cover other care out of state and it’s tough to leave your support system. Things need to CHANGE!”

Clinical trial

More posts featuring Ginny Mason on OncoDaily.